An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors

Abstract Background Sentinel lymph node biopsy (SLNB) after intratumoral injection of 99mTc labeled nanocolloid and imaging with scintigraphy and SPECT/CT in renal tumors is feasible. However, sentinel lymph node (SN) non-detection rate with scintigraphy and SPECT/CT is high. The aim of the study wa...

Full description

Bibliographic Details
Main Authors: Teele Kuusk, Maarten L. Donswijk, Renato A. Valdés Olmos, Roderick E. De Bruijn, Oscar R. Brouwer, Kees Hendricksen, Simon Horenblas, Katarzyna Jóźwiak, Warner Prevoo, Henk G. Van Der Poel, Bas W. G. Van Rhijn, Esther M. Wit, Axel Bex
Format: Article
Language:English
Published: SpringerOpen 2018-12-01
Series:EJNMMI Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13550-018-0460-y
id doaj-e9c1f455e2504430aa8581ff5c99d9cc
record_format Article
spelling doaj-e9c1f455e2504430aa8581ff5c99d9cc2020-11-25T02:31:46ZengSpringerOpenEJNMMI Research2191-219X2018-12-018111110.1186/s13550-018-0460-yAn analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumorsTeele Kuusk0Maarten L. Donswijk1Renato A. Valdés Olmos2Roderick E. De Bruijn3Oscar R. Brouwer4Kees Hendricksen5Simon Horenblas6Katarzyna Jóźwiak7Warner Prevoo8Henk G. Van Der Poel9Bas W. G. Van Rhijn10Esther M. Wit11Axel Bex12Department of Urology, The Netherlands Cancer InstituteDepartment of Nuclear Medicine, The Netherlands Cancer InstituteDepartment of Nuclear Medicine, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Epidemiology and Biostatistics, The Netherlands Cancer InstituteDepartment of Radiology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteDepartment of Urology, The Netherlands Cancer InstituteAbstract Background Sentinel lymph node biopsy (SLNB) after intratumoral injection of 99mTc labeled nanocolloid and imaging with scintigraphy and SPECT/CT in renal tumors is feasible. However, sentinel lymph node (SN) non-detection rate with scintigraphy and SPECT/CT is high. The aim of the study was to determine factors affecting non-visualization (NV) of SN imaging in renal tumors. Seventy-eight patients with cT1–3 renal tumors received intratumoral injection of 225 MBq 99mTc-labeled nanocolloid 1 day before (partial) nephrectomy. Radiotracer injection was followed by anterioposterior and lateral scintigraphy in combination with SPECT/CT 20 min and 2–4 h after. Surgical treatment of the tumor with sentinel lymph node biopsy by aid of γ-probe and-camera was performed the next day. Scintigraphy and SPECT/CT images were evaluated and patient, tumor, and procedure characteristics were collected for 73 eligible patients used in uni- and multivariable analysis of a potential association with NV. Results A total of 80 (mean 1.1, IQR 0–2, max 6) sentinel lymph nodes in 46 patients were detected with scintigraphy and SPECT/CT. Preoperative visualization rate and intraoperative detection rate was 63% [95% CI 50–73%] and 61% [95% CI 49–72%], respectively. In uni- and multivariable analysis, the only factor associated with non-visualization was age, showing higher odds of non-visualization with higher age. Conclusion Our study demonstrated that non-visualization of SNs in renal tumors is relatively high and is associated with patient age. Furthermore, kidneys and also its tumors are highly vascularized which may cause a wash-out effect that could be identified with decreased kidney-liver ratios. However, in our data, the effect was statistically inconclusive. Further studies are needed to improve visualization and standardize the procedure of SLNB in renal tumors. The percentage of NV limits the use of SLNB for research and clinical purposes in renal cancer.http://link.springer.com/article/10.1186/s13550-018-0460-yDetection failureLymphoscintigraphyNanocolloidRenal cell carcinomaSPECT/CTSentinel lymph node
collection DOAJ
language English
format Article
sources DOAJ
author Teele Kuusk
Maarten L. Donswijk
Renato A. Valdés Olmos
Roderick E. De Bruijn
Oscar R. Brouwer
Kees Hendricksen
Simon Horenblas
Katarzyna Jóźwiak
Warner Prevoo
Henk G. Van Der Poel
Bas W. G. Van Rhijn
Esther M. Wit
Axel Bex
spellingShingle Teele Kuusk
Maarten L. Donswijk
Renato A. Valdés Olmos
Roderick E. De Bruijn
Oscar R. Brouwer
Kees Hendricksen
Simon Horenblas
Katarzyna Jóźwiak
Warner Prevoo
Henk G. Van Der Poel
Bas W. G. Van Rhijn
Esther M. Wit
Axel Bex
An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
EJNMMI Research
Detection failure
Lymphoscintigraphy
Nanocolloid
Renal cell carcinoma
SPECT/CT
Sentinel lymph node
author_facet Teele Kuusk
Maarten L. Donswijk
Renato A. Valdés Olmos
Roderick E. De Bruijn
Oscar R. Brouwer
Kees Hendricksen
Simon Horenblas
Katarzyna Jóźwiak
Warner Prevoo
Henk G. Van Der Poel
Bas W. G. Van Rhijn
Esther M. Wit
Axel Bex
author_sort Teele Kuusk
title An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
title_short An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
title_full An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
title_fullStr An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
title_full_unstemmed An analysis of SPECT/CT non-visualization of sentinel lymph nodes in renal tumors
title_sort analysis of spect/ct non-visualization of sentinel lymph nodes in renal tumors
publisher SpringerOpen
series EJNMMI Research
issn 2191-219X
publishDate 2018-12-01
description Abstract Background Sentinel lymph node biopsy (SLNB) after intratumoral injection of 99mTc labeled nanocolloid and imaging with scintigraphy and SPECT/CT in renal tumors is feasible. However, sentinel lymph node (SN) non-detection rate with scintigraphy and SPECT/CT is high. The aim of the study was to determine factors affecting non-visualization (NV) of SN imaging in renal tumors. Seventy-eight patients with cT1–3 renal tumors received intratumoral injection of 225 MBq 99mTc-labeled nanocolloid 1 day before (partial) nephrectomy. Radiotracer injection was followed by anterioposterior and lateral scintigraphy in combination with SPECT/CT 20 min and 2–4 h after. Surgical treatment of the tumor with sentinel lymph node biopsy by aid of γ-probe and-camera was performed the next day. Scintigraphy and SPECT/CT images were evaluated and patient, tumor, and procedure characteristics were collected for 73 eligible patients used in uni- and multivariable analysis of a potential association with NV. Results A total of 80 (mean 1.1, IQR 0–2, max 6) sentinel lymph nodes in 46 patients were detected with scintigraphy and SPECT/CT. Preoperative visualization rate and intraoperative detection rate was 63% [95% CI 50–73%] and 61% [95% CI 49–72%], respectively. In uni- and multivariable analysis, the only factor associated with non-visualization was age, showing higher odds of non-visualization with higher age. Conclusion Our study demonstrated that non-visualization of SNs in renal tumors is relatively high and is associated with patient age. Furthermore, kidneys and also its tumors are highly vascularized which may cause a wash-out effect that could be identified with decreased kidney-liver ratios. However, in our data, the effect was statistically inconclusive. Further studies are needed to improve visualization and standardize the procedure of SLNB in renal tumors. The percentage of NV limits the use of SLNB for research and clinical purposes in renal cancer.
topic Detection failure
Lymphoscintigraphy
Nanocolloid
Renal cell carcinoma
SPECT/CT
Sentinel lymph node
url http://link.springer.com/article/10.1186/s13550-018-0460-y
work_keys_str_mv AT teelekuusk ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT maartenldonswijk ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT renatoavaldesolmos ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT roderickedebruijn ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT oscarrbrouwer ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT keeshendricksen ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT simonhorenblas ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT katarzynajozwiak ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT warnerprevoo ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT henkgvanderpoel ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT baswgvanrhijn ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT esthermwit ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT axelbex ananalysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT teelekuusk analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT maartenldonswijk analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT renatoavaldesolmos analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT roderickedebruijn analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT oscarrbrouwer analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT keeshendricksen analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT simonhorenblas analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT katarzynajozwiak analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT warnerprevoo analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT henkgvanderpoel analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT baswgvanrhijn analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT esthermwit analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
AT axelbex analysisofspectctnonvisualizationofsentinellymphnodesinrenaltumors
_version_ 1724822179568156672